cbdMD Inc
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, ready to drink cans, and sleep, focus, and calming aids. It also provides veterinarian-formulated p… Read more
Market Cap & Net Worth: cbdMD Inc (YCBD)
cbdMD Inc (NYSE MKT:YCBD) has a market capitalization of $6.42 Million ($6.42 Million) as of March 18, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #30397 globally and #10029 in its home market, demonstrating a -7.69% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying cbdMD Inc's stock price $0.72 by its total outstanding shares 8912959 (8.91 Million).
cbdMD Inc Market Cap History: 2017 to 2026
cbdMD Inc's market capitalization history from 2017 to 2026. Data shows change from $1.74 Billion to $6.42 Million (-50.44% CAGR).
cbdMD Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how cbdMD Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.17x
cbdMD Inc's market cap is 0.17 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $1.74 Billion | $4.47 Million | -$1.74 Million | 389.88x | N/A |
| 2018 | $1.24 Billion | $8.42 Million | -$412.07K | 147.19x | N/A |
| 2019 | $906.45 Million | $23.65 Million | -$45.43 Million | 38.33x | N/A |
| 2020 | $1.18 Billion | $41.88 Million | $12.60 Million | 28.25x | 93.89x |
| 2021 | $433.17 Million | $44.48 Million | -$23.39 Million | 9.74x | N/A |
| 2022 | $91.05 Million | $35.40 Million | -$74.09 Million | 2.57x | N/A |
| 2023 | $9.27 Million | $24.16 Million | -$22.94 Million | 0.38x | N/A |
| 2024 | $3.34 Million | $19.48 Million | -$3.70 Million | 0.17x | N/A |
Competitor Companies of YCBD by Market Capitalization
Companies near cbdMD Inc in the global market cap rankings as of March 18, 2026.
Key companies related to cbdMD Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
cbdMD Inc Historical Marketcap From 2017 to 2026
Between 2017 and today, cbdMD Inc's market cap moved from $1.74 Billion to $ 6.42 Million, with a yearly change of -50.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $6.42 Million | -46.67% |
| 2025 | $12.03 Million | +260.00% |
| 2024 | $3.34 Million | -63.94% |
| 2023 | $9.27 Million | -89.82% |
| 2022 | $91.05 Million | -78.98% |
| 2021 | $433.17 Million | -63.39% |
| 2020 | $1.18 Billion | +30.53% |
| 2019 | $906.45 Million | -26.86% |
| 2018 | $1.24 Billion | -28.97% |
| 2017 | $1.74 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of cbdMD Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.42 Million USD |
| MoneyControl | $6.42 Million USD |
| MarketWatch | $6.42 Million USD |
| marketcap.company | $6.42 Million USD |
| Reuters | $6.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.